Immunocore Ownership | Who Owns Immunocore?
Immunocore Ownership Summary
Immunocore is owned by 19.80% institutional investors, 0.07% insiders, and 80.13% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 9.67% of IMCR shares. Vanguard Health Care Inv is the top mutual fund, with 7.19% of its assets in Immunocore shares.
IMCR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunocore | 19.80% | 0.07% | 80.13% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 4.87M | 9.67% | $146.82M |
| Fmr | 4.83M | 9.59% | $145.60M |
| Wellington management group llp | 4.71M | 9.35% | $141.89M |
| Primecap management co/ca/ | 3.69M | 7.34% | $111.35M |
| Bellevue group | 2.80M | 5.56% | $84.32M |
| Vestal point capital, lp | 2.77M | 5.50% | $83.42M |
| Tang capital management | 2.65M | 5.26% | $79.88M |
| Deep track capital, lp | 1.93M | 3.84% | $58.25M |
| T. rowe price investment management | 1.89M | 3.76% | $57.03M |
| Logos global management lp | 1.50M | 2.98% | $45.23M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 2.65M | 4.06% | $79.88M |
| Eschler asset management llp | 80.00K | 2.40% | $2.41M |
| Vestal point capital, lp | 2.77M | 2.33% | $83.42M |
| Logos global management lp | 1.50M | 2.26% | $45.23M |
| Bellevue group | 2.80M | 2.01% | $84.32M |
| Kynam capital management, lp | 884.94K | 1.65% | $26.68M |
| Rtw investments, lp | 4.87M | 1.46% | $146.82M |
| Bvf inc/il | 1.29M | 1.24% | $39.03M |
| Diadema partners lp | 193.19K | 0.99% | $5.82M |
| Deep track capital, lp | 1.93M | 0.95% | $58.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 2.77M | 2.33% | 2.18M |
| Two sigma investments, lp | 1.02M | 0.02% | 661.97K |
| Logos global management lp | 1.50M | 2.26% | 650.00K |
| Point72 asset management | 1.10M | 0.04% | 598.12K |
| Caption management | 661.79K | 0.12% | 567.40K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 1.89M | 0.04% | -4.07M |
| Paradigm biocapital advisors lp | - | - | -1.79M |
| Baker bros. advisors lp | 734.40K | 0.13% | -1.59M |
| General atlantic | - | - | -1.26M |
| Braidwell lp | - | - | -797.27K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Cantor fitzgerald, l. p. | 250.21K | 0.11% | 250.21K | $7.54M |
| Moore capital management, lp | 197.31K | 0.12% | 197.31K | $5.95M |
| Abrdn | 116.86K | 0.01% | 116.86K | $3.52M |
| J. goldman & co lp | 114.75K | 0.10% | 114.75K | $3.46M |
| Balyasny asset management | 113.84K | 0.00% | 113.84K | $3.43M |
Sold Out
| Holder | Change |
|---|---|
| Dv trading | -5.00 |
| Ronald blue trust | -6.00 |
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Northwestern mutual wealth management | -7.00 |
| Geneos wealth management | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 82 | -48.10% | 9,968,249 | -80.66% | 19 | 0.19% | 34 | -56.96% | 28 | -31.71% |
| Dec 31, 2025 | 97 | -32.64% | 12,862,798 | -74.16% | 25 | 0.26% | 49 | -19.67% | 24 | -48.94% |
| Sep 30, 2025 | 136 | -1.45% | 49,176,961 | 2.73% | 97 | 1.08% | 60 | -16.67% | 43 | 7.50% |
| Jun 30, 2025 | 141 | 11.90% | 48,351,355 | 0.95% | 96 | 1.05% | 74 | 23.33% | 40 | 25.00% |
| Mar 31, 2025 | 125 | 2.46% | 47,879,396 | 4.09% | 95 | 1.13% | 61 | 24.49% | 31 | -31.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 3.66M | 7.19% | - |
| Vanguard Capital Opportunity Inv | 2.34M | 4.59% | -193.21K |
| Fidelity Growth Compy Commingled Pl S | 1.67M | 3.29% | -20.74K |
| BB Biotech AG Ord | 1.21M | 2.41% | - |
| Fidelity Growth Compy Commingled Pl O | 1.15M | 2.30% | 101.00 |
| Fidelity Growth Company Fund | 1.16M | 2.29% | -17.50K |
| PRIMECAP Odyssey Aggressive Growth | 1.14M | 2.25% | -74.43K |
| T. Rowe Price U.S. SC Core Eq Tr-D | 1.00M | 1.98% | 10.08K |
| T. Rowe Price U.S. SC Core Eq Tr-Z | 902.33K | 1.83% | 44.96K |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 737.44K | 1.49% | 20.48K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Jallal Bahija | CHIEF EXECUTIVE OFFICER | Sell | $371.18K |
| Feb 18, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Sell | $22.58K |
| Feb 18, 2026 | St Leger Tina Amber | CHIEF HR OFFICER | Sell | $32.35K |
| Feb 18, 2026 | Berman David M | HEAD OF R&D | Sell | $192.97K |
| Dec 04, 2025 | Berman David M | HEAD OF R&D | Sell | $1.26M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | - | - |
IMCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools